EP0147741A3

Pharmaceutical composition with special 1,2-diacyl-glycero-3-phosphocholines for the treatment of diseases of the stomach and the intestines

Abstract

Phospholipide enthaltende, pharmazeutische Zubereitungen zur Behandlung von Erkrankungen im Magen-Darmbereich, die als wirksame Komponente spezielles 1,2-Diacyl-glycero-3-phosphochlin, in dem 75 - 86 Gew.- % der Acylreste ungesättigte Fettsäurereste mit einer Kettenlänge von 16, 18 und oder 20 Kohlenstoffatomen sind, enthalten. Vorzugsweise sind die Fettsäurerestgemische der Acylgruppe in 1 und 2 Stellung unterschiedlich zusammengesetzt. Die Zubereitungen können auch noch andere Wirkstoffe, insbesondere solche die im Magen-Darmbereich schädliche Nebenwirkungen entfalten, enthalten.

Term

Term ended

Projected expiry passed 13 December 2004, 21.8 years ago.

Every citation, both ways

Citations
Document	Relation	Office	Category	Cited during
EP0054769A2	Cites	European Patent Office (EPO)	YD	Search report
FR2343481A1	Cites	France	X	Search report
DE2907778A1	Cites	Germany	X	Search report

19 members in 10 offices

This recordMember, by publication datePriority claim

Priority claims4

Priority claims
Document	Office	Kind	Date
3346525	Germany	A	1983-12-22
3346525	Germany	–	1983-12-22
3346525	–	–	–
DE19833346525	–	–	–

Members19

Family members, oldest first
Document	Office	Kind
DK619884D0	Denmark	D0	1984-12-21
PT79648A	Portugal	A	1985-01-01
GR82544B	Greece	B	1985-04-24
IE843263L	Ireland	L	1985-06-22
DK619884A	Denmark	A	1985-06-23
DE3346525A1	Germany	A1	1985-07-04
EP0147741A2	European Patent Office (EPO)	A2	1985-07-10
ZA849975B	South Africa	B	1985-08-28
JPS60169421A	Japan	A	1985-09-02
EP0147741A3This record	European Patent Office (EPO)	A3	1985-12-04
PT79648B	Portugal	B	1986-10-21
DE3346525C2	Germany	C2	1987-03-19
US4684632A	United States of America	A	1987-08-04
EP0147741B1	European Patent Office (EPO)	B1	1989-08-02
AT45091T	Austria	T	1989-08-15
ATE45091T1	Austria	T1	1989-08-15
DE3479189D1	Germany	D1	1989-09-07
IE57808B1	Ireland	B1	1993-04-21
JPH0577653B2	Japan	B2	1993-10-27

43 legal events, as 3 offices reported them to INPADOC

Over the term

Point at a mark for the event

Events

Legal events, newest first
	Event	Code	Office
2005-02-08	Se: european patent has lapsedLapsedEUG	EUG	EP
2005-02-01	Se: european patent has lapsedLapsedEUG	EUG	EP
2005-02-01	Nl: ceased due to reaching the maximum lifetime of a patentCeasedNLV7	NLV7	EP
2005-01-14	Patent ceasedCeasedPL	PL	CH
2005-01-05	Patent expired after termination of 20 yearsExpiredPE20	PE20	GB
2004-12-31	Be: patent expiredExpiredBE20	BE20	EP
2004-12-13	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2004-12-13	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2004-12-12	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2004-12-12	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2004-12-12	Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25	PG25	EP
2003-12-03	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2003-11-27	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2003-10-24	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2003-10-24	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2003-10-24	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2003-10-23	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2003-10-23	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2003-10-21	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2003-10-13	Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP	PGFP	EP
2002-01-01	European patent in force as of 2002-01-01IF02	IF02	GB
1995-01-31	Se: european patent in force in swedenEAL	EAL	EP
1994-01-21	Lu: last paid annual feeEPTA	EPTA	EP
1990-12-31	It: last paid annual feeITTA	ITTA	EP
1990-08-08	No opposition filedOpposition26N	26N	EP
1990-06-20	No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE	PLBE	EP
1990-06-20	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA	STAA	EP
1989-12-20	Corrections of a patent specification (deleted)D20	D20	EP
1989-12-06	Corrections of a patent specificationR20	R20	EP
1989-11-15	Gb: translation of ep patent filed (gb section 77(6)(a)/1977)GBT	GBT	EP
1989-09-15	Fr: translation filedET	ET	EP
1989-09-07	Corresponds to:REF	REF	EP
1989-09-05	It: translation for a ep patent filedITF	ITF	EP
1989-09-05	It: translation for a ep patent filedITF	ITF	EP
1989-08-02	Designated contracting statesAK	AK	EP
1989-08-02	Corresponds to:REF	REF	EP
1989-06-17	(expected) grantORIGINAL CODE: 0009210GRAA	GRAA	EP
1988-03-02	First examination report despatched17Q	17Q	EP
1986-07-16	Request for examination filed17P	17P	EP
1985-12-04	Designated contracting statesAK	AK	EP
1985-10-03	Search report despatchedORIGINAL CODE: 0009013PUAL	PUAL	EP
1985-07-10	Designated contracting statesAK	AK	EP
1985-05-11	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI	EP

Pharmaceutical composition with special 1,2-diacyl-glycero-3-phosphocholines for the treatment of diseases of the stomach and the intestines

Abstract

Term

Priority claims4

Members19

Over the term

Events

Numbers

Titles3

Classification

Designated states11